Stem Cell Therapy programs being offered abroad?
Our program prioritizes cell quality and regnerative signaling over raw cell counts, and we custom engineer scaffolds even for lean or athletic patients where traditional techniques fail. Our affliates are also among the first in the nation to intregrate regnerative fractional laser technology to enhance tissue receptivity and targeted biologic delivery. All treatments are executed with elite image guided accuracy using fluroscopy, and ultrasound.
What truly sets us apart is not just that we use regenerative medicine, but how precisely we engineer and guide tissue healing. We do not follow a one-size fits all stem cell approach. Instead we practice guided tissue healing through biologic mapping, where imaging, biomechanics, and tissue specific biology detmermine what regenerative approach is used, where it is placed, and how it is scaffolded. We selecitively deploy, cells extracted from patients, including BMAC, MFat, PRP, and fibrinogen scaffolds based on Tissue diffusibility, mechanical load, and healing capacity.
Why 313 MD ?
Highest cell yields in the region
Up to 8 billion MFAT cells and 30–40% higher BMAC output clinics.
ASC-Controlled
procedures
Sterile, image-guided regenerative treatments produce better outcomes.
Rapid access
Appointments within 24–48 hours, MRI review within 72 hours.
Patient-focused
Bundled pricing, outcome dashboards, RTW tracking, and cost-savings reporting.
Complete MSK Ecosystem
- MRI Review
- Interventional Spine
- Regenerative
- PT
- Return to Training
24/7 Online Support
Program Outcomes
- 70–90% surgical avoidance in eligible cases.
- Significant pain reduction within 4–12 weeks
- Return-to-activity in as little as 2–14 days. for many cases.
- 2–5 years of sustained improvement depending on condition.
Overall Actuarial Benefit Summary
- 70–90% reduction in surgical conversions.
- Significant reduction in MSK spending
- 50–337 saved lost work days per affected athlete.
- 2–5X greater cost-efficiency than surgical pathways.
- Improved long-term outcomes and athlete function.
A Smarter MSK Solution
This excludes productivity gains, which often exceed direct cost savings.
313MD with the Regenerative Medicine Institute of Michigan delivers a turnkey, data-driven, regenerative-first MSK solution that outperforms traditional care models in: cost, speed, safety, and patient outcomes.
